{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:16:26Z","timestamp":1787318186566,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","celltherapyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jcyt.2024.03.483","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T12:37:39Z","timestamp":1711802259000},"page":"797-805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Neutrophil generation from hematopoietic progenitor cells and induced pluripotent stem cells (iPSCs): potential applications"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8180-0602","authenticated-orcid":false,"given":"Abdollah","family":"Jafarzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Motaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0825-0213","authenticated-orcid":false,"given":"Sanand Kumar","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Jafarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2024.03.483_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-0154-9_1","article-title":"The role of neutrophils in the immune system: an overview","volume":"2087","author":"Malech","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0002","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fphys.2018.00113","article-title":"Neutrophil: a cell with many roles in inflammation or several cell types?","volume":"9","author":"Rosales","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0003","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.4049\/jimmunol.181.8.5183","article-title":"Homeostatic regulation of blood neutrophil counts","volume":"181","author":"von Vietinghoff","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0004","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4110\/in.2017.17.5.298","article-title":"Current understanding in neutrophil differentiation and heterogeneity","volume":"17","author":"Hong","year":"2017","journal-title":"Immune Netw"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/08977190500055836","article-title":"G-CSF: a key regulator of neutrophil production, but that's not all!","volume":"23","author":"Roberts","year":"2005","journal-title":"Growth Factors"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0006","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev-immunol-020711-074942","article-title":"Neutrophil function: from mechanisms to disease","volume":"30","author":"Amulic","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0007","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/pbc.22885","article-title":"Neutrophil functions in patients with inherited bone marrow failure syndromes","volume":"57","author":"Rochowski","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0008","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.hoc.2019.01.004","article-title":"Congenital neutropenia and rare functional phagocyte disorders in children","volume":"33","author":"Walkovich","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0009","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/JIR.S284941","article-title":"Studying neutrophil function in vitro: cell models and environmental factors","volume":"14","author":"Blanter","year":"2021","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0010","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0011","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0012","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature06534","article-title":"Reprogramming of human somatic cells to pluripotency with defined factors","volume":"451","author":"Park","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0013","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0014","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2008.03.028","article-title":"Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency","volume":"133","author":"Hanna","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1126\/science.1154884","article-title":"Generation of pluripotent stem cells from adult mouse liver and stomach cells","volume":"321","author":"Aoi","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0016","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/jcp.22456","article-title":"Neutrophil differentiation from human-induced pluripotent stem cells","volume":"226","author":"Morishima","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-62703-845-4_12","article-title":"Generation of functionally mature neutrophils from induced pluripotent stem cells","volume":"1124","author":"Sweeney","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0018","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/stem.2332","article-title":"Molecular analysis of neutrophil differentiation from human induced pluripotent stem cells delineates the kinetics of key regulators of hematopoiesis","volume":"34","author":"Sweeney","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0019","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2141.2004.05081.x","article-title":"Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells","volume":"126","author":"Prince","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0020","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1537-2995.2006.01001.x","article-title":"Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity","volume":"46","author":"Boiron","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0021","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0140-6736(99)03113-X","article-title":"Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells","volume":"354","author":"Reiffers","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0022","first-page":"61","article-title":"In vitro expansion of mature neutrophils from isolated peripheral blood stem cells","volume":"43","author":"Hasuike","year":"1997","journal-title":"Osaka City Med J"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0023","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2141.2000.02054.x","article-title":"Ex vivo expansion of mature human neutrophils with normal functions from purified peripheral blood CD34+ haematopoietic progenitor cells","volume":"109","author":"Hino","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0024","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1479-5876-5-53","article-title":"Optimal ex vivo expansion of neutrophils from PBSC CD34+ cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO","volume":"5","author":"Tura","year":"2007","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0025","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/bit.22433","article-title":"Clinical scale ex vivo manufacture of neutrophils from hematopoietic progenitor cells","volume":"104","author":"Timmins","year":"2009","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.102150","article-title":"Neutrophils generated in vitro from hematopoietic stem cells isolated from apheresis samples and umbilical cord blood form neutrophil extracellular traps","volume":"50","author":"Kuhikar","year":"2021","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0027","article-title":"Neutrophils cultured ex vivo from CD34+stem cells are immature and genetically tractable","author":"Naveh","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0028","article-title":"Efficient methods for target gene manipulation in haematopoietic stem cell derived human neutrophils","author":"Cordero","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180832","article-title":"Large-scale ex vivo generation of human neutrophils from cord blood CD34+ cells","volume":"12","author":"Jie","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0030","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1182\/blood-2008-06-160838","article-title":"Derivation of functional mature neutrophils from human embryonic stem cells","volume":"113","author":"Yokoyama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0031","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1172\/JCI38591","article-title":"Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors","volume":"119","author":"Choi","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0032","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1634\/stemcells.2007-0980","article-title":"A feeder-free and efficient production of functional neutrophils from human embryonic stem cells","volume":"27","author":"Saeki","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0033","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/s41598-018-20491-1","article-title":"Secretory factors from OP9 stromal cells delay differentiation and increase the expansion potential of adult erythroid cells in vitro","volume":"8","author":"Trakarnsanga","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0034","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/gtc.12101","article-title":"Establishment and directed differentiation of induced pluripotent stem cells from glycogen storage disease type Ib patient","volume":"18","author":"Satoh","year":"2013","journal-title":"Genes Cells"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/trf.13909","article-title":"Differentiation of induced pluripotent stem cell-derived neutrophil granulocytes from common marmoset monkey (Callithrix jacchus)","volume":"57","author":"Schrimpf","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0036","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.2021011576","article-title":"Efficient production of human neutrophils from iPSCs that prevent murine lethal infection with immune cell recruitment","volume":"138","author":"Miyauchi","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2023.104137","article-title":"AKT2 inhibition accelerates the acquisition of phagocytic ability in induced pluripotent stem cell-derived neutrophils","volume":"130","author":"Hino","year":"2024","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0038","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.stemcr.2019.10.007","article-title":"Effective and rapid generation of functional neutrophils from induced pluripotent stem cells using ETV2-modified mRNA","volume":"13","author":"Brok-Volchanskaya","year":"2019","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0039","doi-asserted-by":"crossref","first-page":"100075","DOI":"10.1016\/j.xpro.2020.100075","article-title":"Generation of human neutrophils from induced pluripotent stem cells in chemically defined conditions using ETV2 modified mRNA","volume":"1","author":"Majumder","year":"2020","journal-title":"STAR Protoc"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/sctm.18-0255","article-title":"Neutrophils derived from genetically modified human induced pluripotent stem cells circulate and phagocytose bacteria in vivo","volume":"8","author":"Trump","year":"2019","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0041","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3324\/haematol.2013.083873","article-title":"Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis","volume":"99","author":"Morishima","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0042","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fmed.2019.00021","article-title":"Ex vivo manufactured neutrophils for treatment of neutropenia: a process economic evaluation","volume":"6","author":"Torres-Acosta","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0043","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1016\/j.ijid.2009.02.021","article-title":"Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG)","volume":"14","author":"Lech-Maranda","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0044","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3109\/14653249.2010.518610","article-title":"Short-term exposure of umbilical cord blood CD34+ cells to granulocyte\u2013macrophage colony-stimulating factor early in culture improves ex vivo expansion of neutrophils","volume":"13","author":"Marturana","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1537-2995.2006.00693.x","article-title":"Granulocyte transfusion therapy: it's time for an answer","volume":"46","author":"Price","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0046","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood.V95.11.3302.010k35_3302_3309","article-title":"Phase I\/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation","volume":"95","author":"Price","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0047","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1200\/JCO.20.01739","article-title":"Open-label phase II prospective, randomized, controlled study of romyelocel-L myeloid progenitor cells to reduce infection during induction chemotherapy for acute myeloid leukemia","volume":"39","author":"Desai","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0048","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1086\/491743","article-title":"Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted","volume":"192","author":"Arber","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0049","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/JLB.4HI1221-722R","article-title":"Transfusable neutrophil progenitors as cellular therapy for the prevention of invasive fungal infections","volume":"111","author":"Sykes","year":"2022","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1098-1101(1997)12:2<74::AID-JCA4>3.0.CO;2-6","article-title":"Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis","volume":"12","author":"Vamvakas","year":"1997","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0051","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/BS9.0000000000000023","article-title":"Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy","volume":"1","author":"Zhu","year":"2019","journal-title":"Blood Sci"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0052","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/cell.2023.0041","article-title":"Induced pluripotent stem cell-derived chimeric antigen receptor T cells: the intersection of stem cells and immunotherapy","volume":"25","author":"Lahimchi","year":"2023","journal-title":"Cell Reprogram"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0053","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/cancers16030623","article-title":"Chimeric antigen receptor T cell and chimeric antigen receptor NK cell therapy in pediatric and adult high-grade glioma-recent advances","volume":"16","author":"Kowalczyk","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111128","article-title":"Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy","volume":"40","author":"Chang","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0055","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/s41467-023-37872-4","article-title":"CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy","volume":"14","author":"Chang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.regen.2023.100074","article-title":"Engineered anti-prostate cancer CAR-neutrophils from human pluripotent stem cells","volume":"20","author":"Harris","year":"2023","journal-title":"J Immunol Regenerat Med"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0057","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/nm.2514","article-title":"The neutrophil in vascular inflammation","volume":"17","author":"Phillipson","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0058","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202003598","article-title":"Neutrophils enable local and non-invasive liposome delivery to inflamed skeletal muscle and ischemic heart","volume":"32","author":"Che","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0059","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/bloodadvances.2020003214","article-title":"PML-controlled responses in severe congenital neutropenia with ELANE-misfolding mutations","volume":"5","author":"Olofsen","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41434-020-0127-y","article-title":"Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells","volume":"27","author":"Hoffmann","year":"2020","journal-title":"Gene Ther"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0061","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1172\/JCI80924","article-title":"Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells","volume":"125","author":"Nayak","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0062","doi-asserted-by":"crossref","first-page":"e17565","DOI":"10.1371\/journal.pone.0017565","article-title":"Generation of functional neutrophils from a mouse model of X-linked chronic granulomatous disorder using induced pluripotent stem cells","volume":"6","author":"Mukherjee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0063","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/biores.2014.0045","article-title":"Optimized generation of functional neutrophils and macrophages from patient-specific induced pluripotent stem cells: ex vivo models of X(0)-linked, AR22(0)- and AR47(0)- chronic granulomatous diseases","volume":"3","author":"Brault","year":"2014","journal-title":"Biores Open Access"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0064","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biomaterials.2015.07.057","article-title":"TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells","volume":"69","author":"Dreyer","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0065","doi-asserted-by":"crossref","DOI":"10.19185\/matters.201805000005","article-title":"Lentiviral gene therapy vector with UCOE stably restores function in iPSC-derived neutrophils of a CDG patient","author":"Haenseler","year":"2018","journal-title":"Matters (Zur)"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.748519","article-title":"The use of induced pluripotent stem cells to study the effects of adenosine deaminase deficiency on human neutrophil development","volume":"12","author":"Tsui","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0067","doi-asserted-by":"crossref","first-page":"e31357","DOI":"10.1097\/MD.0000000000031357","article-title":"Severe congenital neutropenia caused by ELANE gene mutation: a case report and literature review","volume":"101","author":"Wang","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0068","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2006-11-057299","article-title":"Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis","volume":"110","author":"Grenda","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0069","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3324\/haematol.2019.221804","article-title":"CRISPR\/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients","volume":"105","author":"Nasri","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0070","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1515\/tjb-2019-0089","article-title":"A method for high-purity isolation of neutrophil granulocytes for functional cell migration assays","volume":"44","author":"Avci","year":"2019","journal-title":"Turk J Biochem"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0071","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1046\/j.1537-2995.1983.23684074273.x","article-title":"Prolonged cryopreservation of human granulocytes","volume":"23","author":"Richman","year":"1983","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0072","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/scd.2014.0292","article-title":"Temporal analysis of genome alterations induced by single-cell passaging in human embryonic stem cells","volume":"24","author":"Bai","year":"2015","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0073","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1038\/ncomms6507","article-title":"Targeted and genome-wide sequencing reveal single nucleotide variations impacting specificity of Cas9 in human stem cells","volume":"5","author":"Yang","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0074","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nbt.1835","article-title":"Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells","volume":"29","author":"Taapken","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcyt.2024.03.483_bib0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.addr.2017.09.004","article-title":"Genome stability of programmed stem cell products","volume":"120","author":"Martin","year":"2017","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924005772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924005772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T04:43:39Z","timestamp":1731645819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324924005772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1465324924005772"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.03.483","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophil generation from hematopoietic progenitor cells and induced pluripotent stem cells (iPSCs): potential applications","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.03.483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}